Moviprep and Phenergan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate) and Phenergan (promethazine hydrochloride). Common drug interactions include deep vein thrombosis among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Moviprep and Phenergan. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Phenergan?

Phenergan has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 25,312 Phenergan users. Check the latest studies of Phenergan.

On Jul, 11, 2026

16 people who take Moviprep and Phenergan together, and have interactions are studied.

Moviprep and Phenergan drug interactions.

What are the common drug interactions of Moviprep and Phenergan, by gender? *:

female:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Ascites (accumulation of fluid in the abdominal cavity)
Gastrointestinal obstruction
Anaemia (lack of blood)
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Ileus (a painful obstruction of the ileum or other part of the intestine)
Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Thymoma (a tumour originating from the epithelial cells of the thymus)

male:

Drug ineffective
Arthralgia (joint pain)
Weight increased
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Drug administration error
Drug dependence
Hypertension (high blood pressure)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Psoriasis (immune-mediated disease that affects the skin)

What are the common drug interactions of Moviprep and Phenergan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Arthralgia (joint pain)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Cough
Diarrhoea
Drug administration error
Drug dependence
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)

60+:

Ascites (accumulation of fluid in the abdominal cavity)
Pneumonia
Thymoma (a tumour originating from the epithelial cells of the thymus)
Ventricular fibrillation (abnormally irregular heart rhythm)

What are the existing conditions these people have? *

Constipation: 8 people, 50.00%
Pain: 7 people, 43.75%
High Blood Pressure: 6 people, 37.50%
Ill-Defined Disorder: 5 people, 31.25%
Asthma: 5 people, 31.25%
Hot Flush (sudden feelings of heat): 5 people, 31.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 18.75%
Ovarian Cancer (cancer of ovary): 3 people, 18.75%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 18.75%
Cough: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and Phenergan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously